These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2236164)
1. Dose intensification using combination alkylating agents and autologous bone marrow support in the treatment of primary and metastatic breast cancer: a review of the Duke Bone Marrow Transplantation Program experience. Peters WP Prog Clin Biol Res; 1990; 354B():185-94. PubMed ID: 2236164 [No Abstract] [Full Text] [Related]
2. A perspective on dose-intensive therapy with autologous bone marrow transplantation for solid tumors. Ayash LJ; Antman K; Cheson BD Oncology (Williston Park); 1991 Mar; 5(3):25-33; discussion 33, 36, 41. PubMed ID: 1829944 [TBL] [Abstract][Full Text] [Related]
3. Dose intensity studies in breast cancer--autologous bone marrow transplantation. Hortobagyi GN; Dunphy F; Buzdar AU; Spitzer G Prog Clin Biol Res; 1990; 354B():195-209. PubMed ID: 2236166 [No Abstract] [Full Text] [Related]
4. The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer. Peters WP; Ross M; Vredenburgh JJ; Hussein A; Rubin P; Dukelow K; Cavanaugh C; Beauvais R; Kasprzak S Semin Oncol; 1994 Aug; 21(4 Suppl 7):25-31. PubMed ID: 7916487 [TBL] [Abstract][Full Text] [Related]
5. High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer. Eder JP; Antman K; Peters W; Henner WD; Elias A; Shea T; Schryber S; Andersen J; Come S; Schnipper L J Clin Oncol; 1986 Nov; 4(11):1592-7. PubMed ID: 3534155 [TBL] [Abstract][Full Text] [Related]
6. Long-term results of induction- and intensification chemotherapy supported with autologous bone marrow reinfusion in patients with disseminated or T4 breast cancer. Mulder NH; Dolsma WV; Mulder PO; De Vries EG; Willemse PH; Sleijfer DT; Hospers GA; Van der Graaf WT Anticancer Res; 1995; 15(4):1565-8. PubMed ID: 7654046 [TBL] [Abstract][Full Text] [Related]
7. High-dose chemotherapy, autologous bone marrow or stem cell transplantation and post-transplant consolidation chemotherapy in patients with advanced breast cancer. Tallman MS; Rademaker AW; Jahnke L; Brown SG; Bauman A; Mangan C; Kelly C; Rubin H; Kies MS; Shaw J; Kiel K; Gordon LI; Gradishar WJ; Winter JN Bone Marrow Transplant; 1997 Nov; 20(9):721-9. PubMed ID: 9384473 [TBL] [Abstract][Full Text] [Related]
8. High-dose chemotherapy with autologous stem cell rescue in women with metastatic breast cancer with involved bone marrow: a role for peripheral blood progenitor transplant. Myers SE; Mick R; Williams SF Bone Marrow Transplant; 1994 Apr; 13(4):449-54. PubMed ID: 8019470 [TBL] [Abstract][Full Text] [Related]
9. High-dose therapy in breast cancer: out of favor but not out of promise. Glück S; Stewart D Bone Marrow Transplant; 2000 May; 25(10):1017-9. PubMed ID: 10828859 [TBL] [Abstract][Full Text] [Related]
10. High-dose chemotherapy with autologous bone marrow support as consolidation after standard-dose adjuvant therapy in primary breast cancer patients with seven or more involved axillary lymph nodes. Lalisang RI; Hupperets PS; ten Haaft MA; Jansen RL; Schouten HC Bone Marrow Transplant; 1998 Feb; 21(3):243-7. PubMed ID: 9489646 [TBL] [Abstract][Full Text] [Related]
11. Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation. Chen TL; Passos-Coelho JL; Noe DA; Kennedy MJ; Black KC; Colvin OM; Grochow LB Cancer Res; 1995 Feb; 55(4):810-6. PubMed ID: 7850794 [TBL] [Abstract][Full Text] [Related]
12. Autologous bone marrow support and bone disease in metastatic breast cancer. Nabholtz JM; al-Tweigeri T; Jacquelin N; Venner PM Can J Oncol; 1995 Jul; 5(2):369-75. PubMed ID: 8853509 [TBL] [Abstract][Full Text] [Related]
13. [Experience with other tumors: breast, ovary, brain tumors and sarcomas]. Maraninchi D; Droz JP Bull Cancer; 1995; 82 Suppl 1():66s-72s. PubMed ID: 7626857 [TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy with autologous bone marrow transplantation for the treatment of breast cancer: yes. Peters WP Important Adv Oncol; 1995; ():215-30. PubMed ID: 7672808 [No Abstract] [Full Text] [Related]
15. High-dose chemotherapy with bone marrow support for solid tumors. Antman K; Eder JP; Frei E Important Adv Oncol; 1987; ():221-35. PubMed ID: 2841230 [No Abstract] [Full Text] [Related]
16. High-dose chemotherapy and autologous bone marrow support for breast cancer. Peters WP Important Adv Oncol; 1991; ():135-50. PubMed ID: 1869274 [No Abstract] [Full Text] [Related]
17. High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out. Smith GA; Henderson IC Important Adv Oncol; 1995; ():201-14. PubMed ID: 7672807 [No Abstract] [Full Text] [Related]
18. High-dose combination alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute/Beth Israel Hospital experience. Antman K; Eder JP; Elias A; Shea T; Peters WP; Andersen J; Schryber S; Henner WD; Finberg R; Wilmore D Cancer Treat Rep; 1987 Feb; 71(2):119-25. PubMed ID: 3542208 [TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer. Gisselbrecht C; Extra JM; Lotz JP; Devaux Y; Janvier M; Peny AM; Guillevin L; Bremond D; Delain M; Herbrecht R; Lepage E; Maraninchi D Bone Marrow Transplant; 1996 Nov; 18(5):857-63. PubMed ID: 8932837 [TBL] [Abstract][Full Text] [Related]
20. [High-dose therapy and hematopoietic cell autotransplantation in the treatment of adult gynecologic tumors]. Lotz JP; Pene F; Bouleuc C; André T; Gligorov J; Avenin D; Esteso A; Bellaiche A; Macovei C; Merad Z; Laadem A; Vanica R; Izrael V Contracept Fertil Sex; 1996 Apr; 24(4):307-18. PubMed ID: 8704806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]